Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia. (2015)
Attributed to:
Characterising and targeting aberrant enhancer function in acute myeloid leukaemia (AML)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1177/2040620715577614
PubMed Identifier: 26137202
Publication URI: http://europepmc.org/abstract/MED/26137202
Type: Journal Article/Review
Volume: 6
Parent Publication: Therapeutic advances in hematology
Issue: 3
ISSN: 2040-6207